Jane Street Group LLC Boosts Holdings in Integer Holdings Co. (NYSE:ITGR)

Jane Street Group LLC boosted its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 23.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 151,397 shares of the medical equipment provider's stock after buying an additional 28,572 shares during the quarter. Jane Street Group LLC owned approximately 0.45% of Integer worth $19,682,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Contravisory Investment Management Inc. boosted its holdings in Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 80 shares in the last quarter. Huntington National Bank boosted its stake in shares of Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock valued at $35,000 after purchasing an additional 268 shares in the last quarter. Quest Partners LLC increased its position in shares of Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock valued at $39,000 after buying an additional 332 shares during the period. GAMMA Investing LLC raised its stake in Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider's stock worth $85,000 after buying an additional 278 shares in the last quarter. Finally, Innealta Capital LLC purchased a new stake in Integer in the second quarter worth about $110,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Stock Up 1.0 %

Shares of NYSE:ITGR traded up $1.35 during trading on Tuesday, reaching $139.66. 304,138 shares of the stock traded hands, compared to its average volume of 304,783. The stock has a market cap of $4.68 billion, a P/E ratio of 43.10, a price-to-earnings-growth ratio of 2.00 and a beta of 1.12. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The stock has a 50-day moving average of $132.80 and a two-hundred day moving average of $125.29. Integer Holdings Co. has a 52-week low of $89.65 and a 52-week high of $142.76.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. The business had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company's revenue was up 8.7% compared to the same quarter last year. During the same period last year, the business posted $1.27 EPS. As a group, sell-side analysts expect that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ITGR has been the subject of a number of research reports. Truist Financial decreased their price objective on Integer from $150.00 to $147.00 and set a "buy" rating for the company in a report on Friday, October 25th. Citigroup increased their price target on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research note on Tuesday, October 1st. KeyCorp boosted their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 15th. Bank of America raised their target price on shares of Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company reiterated an "overweight" rating and set a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $142.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.